2Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Researcb Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or mefformin [ J ]. N Engl J Med, 2002, 346:393 -403.
3Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study [ J ]. BMJ, 2000, 321:405-412.
4International Diabetes Federation. Global Guideline for Type 2 Diabetes: Blood Pressure Control [ EB/OL]. http://www. idf. org/Global_guideline. 2005.
6Hoogwerf BJ. Postoperative management of the diabetic patient[J]. Med Clin North Am, 2001,85: 1213 - 1228.
7Marks JB. Perioperative management of diabetes [ J ]. Am Fam Physician, 2003, 67:93 - 100.
8van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients[J]. N Engl J Med, 2001, 345:1359 - 1367.
9Canadian Diabetes Association Clinical Practice Guidelines Ex- pert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada [ J ]. Canadian Journal of diabetes, 2003, 27 : S113 -116.
10American Diabetes Association Workgroup on hypoglycemia. Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia[ J]. Diabetes Care, 2005, 28:1245 -1249.
10World Health Organization. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
